We are live on ! Find out more
CS

Comerica Securities Portfolio holdings

AUM $1.2B
1-Year Est. Return 16.58%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+16.58%
3 Year Est. Return
+25.63%
5 Year Est. Return
+49.47%
10 Year Est. Return
+131.77%
AUM
$723M
AUM Growth
+$49.8M
Cap. Flow
+$25.3M
Cap. Flow %
3.5%
Top 10 Hldgs %
22.87%
Holding
413
New
29
Increased
206
Reduced
142
Closed
17

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.5M
2
GILD icon
Gilead Sciences
GILD
+$2.91M
3
EMR icon
Emerson Electric
EMR
+$2.89M
4
PFE icon
Pfizer
PFE
+$2.82M
5
WFC icon
Wells Fargo
WFC
+$2.63M

Sector Composition

Rank Sector Weight
1 Healthcare 6.8%
2 Financials 6.79%
3 Technology 5.85%
4 Industrials 4.93%
5 Energy 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
301
Target
TGT
$61.1B
$356K 0.05%
6,040
-66
-1% -$3.7K
BIIB icon
302
Biogen
BIIB
$29.6B
$353K 0.05%
1,126
PANW icon
303
Palo Alto Networks
PANW
$265B
$351K 0.05%
14,610
+4,836
+49% +$110K
BDX icon
304
Becton Dickinson
BDX
$42.1B
$348K 0.05%
1,822
-50
-3% -$9.69K
BMY icon
305
Bristol-Myers Squibb
BMY
$126B
$342K 0.05%
5,359
-39
-0.7% -$2.28K
KMI icon
306
Kinder Morgan
KMI
$72.9B
$339K 0.05%
17,686
-3,981
-18% -$77.6K
SHV icon
307
iShares 0-1 Year Treasury Bond ETF
SHV
$20.7B
$339K 0.05%
3,069
-222
-7% -$24.5K
XRAY icon
308
Dentsply Sirona
XRAY
$2.55B
$336K 0.05%
5,607
+2,018
+56% +$120K
NDAQ icon
309
Nasdaq
NDAQ
$51.1B
$331K 0.05%
12,813
+2,877
+29% +$71.5K
VAW icon
310
Vanguard Materials ETF
VAW
$2.96B
$329K 0.05%
2,544
+494
+24% +$61.4K
SMFG icon
311
Sumitomo Mitsui Financial
SMFG
$165B
$327K 0.05%
42,376
+1,298
+3% +$9.89K
SYK icon
312
Stryker
SYK
$122B
$323K 0.04%
2,271
-50
-2% -$7.17K
WBA
313
DELISTED
Walgreens Boots Alliance
WBA
$320K 0.04%
4,138
-120
-3% -$9.62K
CLB icon
314
Core Laboratories
CLB
$544M
$318K 0.04%
3,221
+461
+17% +$44.7K
ADP icon
315
Automatic Data Processing
ADP
$97.1B
$315K 0.04%
2,864
EEMV icon
316
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.48B
$315K 0.04%
5,416
+12
+0.2% +$689
PHG icon
317
Philips
PHG
$25.3B
$313K 0.04%
10,012
+159
+2% +$4.63K
UBS icon
318
UBS Group
UBS
$169B
$313K 0.04%
18,226
+949
+5% +$16.2K
ITM icon
319
VanEck Intermediate Muni ETF
ITM
$2.14B
$311K 0.04%
+6,460
New +$312K
AGN
320
DELISTED
Allergan plc
AGN
$310K 0.04%
1,512
+96
+7% +$22.3K
WPP icon
321
WPP
WPP
$3.91B
$301K 0.04%
3,246
-575
-15% -$56.4K
FXO icon
322
First Trust Financials AlphaDEX Fund
FXO
$1.1B
$300K 0.04%
10,095
-235
-2% -$6.82K
MMS icon
323
Maximus
MMS
$3.02B
$299K 0.04%
4,631
+629
+16% +$38.6K
PCY icon
324
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$298K 0.04%
+10,018
New +$296K
RDS.B
325
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$298K 0.04%
4,760
-339
-7% -$19.5K

Similar funds

Comerica Securities's Q3 2017 Portfolio in Review

As of Q3 2017, Comerica Securities held 413 positions worth $723M, up 7.4% from $673M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Comerica Securities deployed $25.3M of net new capital in Q3 2017, opening 29 new positions and adding to 206 existing holdings. Its largest new stake was Las Vegas Sands: 23,017 shares worth $1.48M.

By sector, the portfolio is most concentrated in Healthcare at 6.8% of assets, up from 6.4% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sysco, an estimated $1.35M trimmed.

  • Comerica Securities's largest Q3 2017 buy was Las Vegas Sands: 23,017 shares worth $1.48M.
  • Comerica Securities added most to iShares Core S&P 500 ETF in Q3 2017, an estimated $3.5M increase.
  • Comerica Securities's biggest Q3 2017 reduction was Sysco, cutting an estimated $1.35M.
  • Comerica Securities fully exited Encompass Health in Q3 2017, selling an estimated $3.3M.
  • Comerica Securities's ten largest holdings make up 23% of its $723M portfolio in Q3 2017.
  • Comerica Securities opened 29 new positions and closed 17 in Q3 2017.
  • Comerica Securities's portfolio value rose 7.4% quarter-over-quarter to $723M.

Based on Comerica Securities's 13F filing for Q3 2017, filed 13 Nov 2017.